healthcare
Boston Scientific trims outlook again
Boston Scientific trims 2026 sales and earnings guidance due to slowing growth in key product lines, including Watchman and electrophysiology, affecting its…
Abbott Launches Study Amid Crowded Heart Valve Market
Abbott launches a comprehensive heart valve study assessing its TriClip device's real-world safety and performance in treating tricuspid valves.
Boston Scientific Plans Restructuring $800M Charges Expected
Boston Scientific restructuring plan will incur up to $800 M in pre‑tax charges as the company shifts production and cuts jobs to…
User Account Blocked by Administrators
Prevent drug diversion with multidisciplinary auditing and procurement checks beyond diversion surveillance software effectively.
User Blocked from Online Access
Discover the latest guidance on switching disease-modifying therapies for multiple sclerosis patients, focusing on hit-hard-and-early treatment era strategies f
User Account Blocked by Moderators
Sacituzumab govitecan is a new first-line treatment option for breast cancer patients with metastatic triple-negative breast cancer.
User Blocked from Accessing System
Cancer patients often blur lines between cancer care and everyday medical management, requiring adaptability from oncologists and primary care doctors in cancer
Sorry, You Have Been Blocked
Prevent liver disease and death with HBV/HCV screening and vaccination. Learn how combining testing and early treatment improves detection rates.
User access denied after system block
Treating blood cancer in prisons requires specialized care and planning to overcome unique challenges for inmates. Learn effective strategies.
User Blocked After Repeated Policy Violations
MASH predictors reveal cardiovascular and kidney risks that drive rapid liver scarring and soaring healthcare costs, highlighting urgent need for targeted inter